|Podcasts|January 6, 2011

INC Research Discusses How CROs Can Help Oncology Trials

INC Research Discusses How CROs Can Help Oncology Trials

Dr. Mike Kurman, Senior Medical Director, Oncology and Patrick Melvin, Executive Director, Oncology at INC Research discuss the barriers to oncology drug development and how CROs are uniquely positioned to help pharma improve this process.

Dr. Mike Kurman, Senior Medical Director, Oncology, INC Research

Patrick Melvin, Executive Director, Oncology, INC Research

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

Unlock Commercial Growth through Data-Driven Patient and HCP Insights Podcast

May 2nd 2025

Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit

February 7th 2025

Thinking Big for Small and Mid-Sized Biotechs: How Applying Modeling and Simulation Technologies Can Improve Drug Development

January 6th 2023

The Evolving Relationship Between Sponsors and the Contract Research Organizations

December 8th 2022

The MDR: Navigating Europe’s New Standard for Medical Device Safety

October 25th 2022

Trending on Applied Clinical Trials Online

Beyond Compliance: AJNA BioSciences' Joel Stanley on Bringing Botanical Medicine Through the FDA Pathway

Where AI Is Delivering Real Value in Clinical Trial Payments Right Now

ACT Brief: AI in Invoice Processing, Botanical Medicines and FDA Pathways, and Connected Trial Finance Systems

From Doing to Reviewing: How a Connected Ecosystem Streamlines Clinical Trial Finance

ACT Brief: Payment Infrastructure and Site Cash, Inspection Readiness Throughout Execution, and First Hemolytic Anemia Therapy